MarkNtel Advisors, a leading market research firm, has showed its latest study titled "Global Radiopharmaceuticals Market", offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Analysis and Insights into the Global Radiopharmaceuticals Market: 2024-2030
The Global Radiopharmaceuticals Market is estimated to grow at a CAGR of around 10.02% during the forecast period, i.e., 2024-30.
Download the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this Report - https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
Global Radiopharmaceuticals Market Driver:
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.
Global Radiopharmaceuticals Market Segmentation:
The Global Radiopharmaceuticals Market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.
By Radioisotope
-Technetium 99- Market Size & Forecast 2019-2030, USD Million
-Fluorine 18- Market Size & Forecast 2019-2030, USD Million
-Iodine 131- Market Size & Forecast 2019-2030, USD Million
-Gallium 68- Market Size & Forecast 2019-2030, USD Million
-Iodine 123- Market Size & Forecast 2019-2030, USD Million
-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million
By Indication
-Oncology- Market Size & Forecast 2019-2030, USD Million
-Cardiology- Market Size & Forecast 2019-2030, USD Million
-Gastroenterology- Market Size & Forecast 2019-2030, USD Million
-Nephrology- Market Size & Forecast 2019-2030, USD Million
-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million
By Type
-Diagnostic- Market Size & Forecast 2019-2030, USD Million
-Therapeutic- Market Size & Forecast 2019-2030, USD Million
By End User
-Hospitals- Market Size & Forecast 2019-2030, USD Million
-Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million
-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million.
Geographical Analysis into the Global Radiopharmaceuticals Market:
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Read Detailed Index of full Research Study at – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
Competitive Landscape and Global Radiopharmaceuticals Market Share Analysis:
The competitive landscape of the Global Radiopharmaceuticals Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.
The report features major players including:
Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.
Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Questions Addressed in this Study
- What factors are driving the Global Radiopharmaceuticals Market growth?
- How is the Global Radiopharmaceuticals Market expected to grow over the next five years?
- What are the key insights into the current trends in the Global Radiopharmaceuticals Market?
- What is the current size of the Global Radiopharmaceuticals Market, and how is it projected to change in the future?
- What is the future outlook for the Global Radiopharmaceuticals Market in terms of technological advancements and market expansion?
Why choose MarkNtel?
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call: ? +1 628 895 8081 +91 120 4278433
Email: ? sales@marknteladvisors.com
Visit to know more: ? https://www.marknteladvisors.com
